9 November 2022
9 November 2022 07:00 GMT PT027 recommended by FDA advisory committee as new rescue treatment for asthma First and only rescue medication recommended for…
8 November 2022
3i Infrastructure plc Half-yearly report 2022 Review from the Managing Partners 3i Infrastructure’s excellent performance during the period has demonstrated, once again, that this…
AVI GLOBAL TRUST PLC (‘AGT’ or the ‘Company’) LEI: 213800QUODCLWWRVI968 Annual Financial Report for the year ended 30 September 2022 A copy of the…
Annual Results Announcement YEAR ENDED 17 SEPTEMBER 2022 FOR RELEASE 8 NOVEMBER 2022 Robust delivery in food; retail performance strongly ahead Financial Headlines Actual…
Persimmon plc today announces its Trading Statement which covers the period from 1 July 2022 to 7 November 2022 (‘the period’). Dean Finch, Group Chief…
AVI Global Trust plc Appointment of new Chairman AVI Global Trust appoints Graham Kitchen as new Chairman AVI Global Trust plc (the “Company”) today…
Issued: 7 November 2022, London UK GSK provides update on DREAMM-3 phase III trial for Blenrep in relapsed/refractory multiple myeloma GSK plc (LSE/NYSE: GSK) today announced…
4 November 2022
4 November 2022 07:00 GMT Beyfortus approved in the EU for the prevention of RSV lower respiratory tract disease in infants First and only single-dose…